BackArtiva Biotherapeutics Overview

Artiva Biotherapeutics Accounts Payable

Track Artiva Biotherapeutics's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Artiva Biotherapeutics Accounts Payable History

Loading

Artiva Biotherapeutics vs. peers: Accounts Payable Comparison

Loading

Artiva Biotherapeutics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Artiva Biotherapeutics (ARTV) FAQ

The latest accounts payable for ARTV is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Artiva Biotherapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARTV's accounts payable moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Artiva Biotherapeutics's operating scale or balance-sheet position.

A accounts payable figure of $0 for ARTV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ARTV's accounts payable ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.